Skip to content

Author

I. Panaccione

We have 2 of 42 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Reduced Anticipatory Pleasure in Early-Onset Severe Cannabis Use Disorder: A Retrospective, Cross-Sectional Study

Background: Cannabis is the most widely used illicit substance, particularly among youth. Earlier onset is associated with poorer clinical trajectories in cannabis use disorder (CUD), but its relationship with hedonic–motivational components remains unclear. Methods: Outpatients with severe CUD (n = 121) were stratifie...

M. Pepe, Francesco Traccis, G. Mandracchia et al. · 0 citations
Review Open access Aug 2026

Evaluating seltorexant as a treatment option for major depressive disorder

Seltorexant 20 mg has shown a promising antidepressant effect, particularly in patients with clinically significant insomnia, and a favorable tolerability profile, and the mixed phase-3 results, the modest effect sizes, and gaps on core symptoms of depression warrant a measured positive view, pending confirmatory data.

M. Di Nicola, M. Pepe, I. Marcelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.